Improvement in the health of HIV-infected persons in care: reducing disparities.
about
Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected PatientsHIV-1 Genetic Variability and Clinical ImplicationsBarriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era.The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.Immune activation in HIV-infected aging women on antiretrovirals--implications for age-associated comorbidities: a cross-sectional pilot study.California's "Bridge to Reform": identifying challenges and defining strategies for providers and policymakers implementing the Affordable Care Act in low-income HIV/AIDS care and treatment settings.Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States.Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding DomainAddressing the challenges of the HIV continuum of care in high-prevalence cities in the United States.A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.Trends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort.Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected WomenPatterns of HIV service use and HIV viral suppression among patients treated in an academic infectious diseases clinic in North Carolina.Substance Abuse Treatment, HIV/AIDS, and the Continuum of Response for People Who Inject Drugs.Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention InitiativeSex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals.Higher quality communication and relationships are associated with improved patient engagement in HIV careAssociation of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United StatesImmune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.The Rationale, Design, and Initial Efficacy of SystemCHANGE(™) -HIV: A Systems-Based Intervention to Improve Physical Activity in People Living with HIV.High Hepatitis C cure rates among black and non-black HIV-infected adults in an urban center.Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada.Trends in Racial and Ethnic Disparities in Antiretroviral Therapy Prescription and Viral Suppression in the United States, 2009-2013.Black:White Disparities in HIV Mortality in the United States: 1990-2009.Incidence, Long-Term Outcomes, and Healthcare Utilization of Patients With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Disseminated Mycobacterium avium Complex From 1992-2015.Comprehensive Ryan White Assistance and HIV Clinical Outcomes: Retention in Care and Viral Suppression in a Medicaid Non-Expansion State.Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies.Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels.Racial/ethnic disparities in engagement in care and viral suppression in a large urban HIV clinic.Financial Barriers and Lapses in Treatment and Care of HIV-Infected Adults in a Southern State in the United States.Influence of model assumptions about HIV disease progression after initiating or stopping treatment on estimates of infections and deaths averted by scaling up antiretroviral therapy.The Contribution of Missed Clinic Visits to Disparities in HIV Viral Load Outcomes.The influence of race and comorbidity on the timely initiation of antiretroviral therapy among older persons living with HIV/AIDS.
P2860
Q28535233-0772EBE4-CAB8-4993-B252-FF7E1898D5F9Q28548003-FBCEEA70-EB52-48F9-B0EB-425FABF8DBAEQ30352010-AB09C3A3-2D0A-42EB-9B1D-CC59CAE3A49FQ33629538-007F8440-D199-40C9-AAFA-2436838EB24FQ33705883-48EAD391-3575-48E9-8036-0EA5CD8CFE3AQ34749335-91E4C0CB-D588-498B-8267-5475FA79D3F1Q35112164-FBF04CAF-BFC5-4B55-BF1D-18E122E23C8EQ35661732-A2F062DF-03F0-4955-BE12-F8D27C052609Q35692184-0B0933B3-A396-4926-8817-78B7DAC4B4A7Q35781306-6D20527D-39D7-48D2-B684-CE88ABE5DA98Q35996628-7D5B07CF-EA5D-4E4F-B261-326580421DDBQ36030846-C932EF1F-48A4-4F62-BC12-FE09568ACF53Q36275359-9BEFD5A8-B9B2-4BEB-B713-EE875E1CE931Q36278787-3734D74A-A65F-4F54-8A77-99B12E8D5F1BQ36395144-BE96C891-F40D-44D1-A180-8A6862248B2AQ36454818-A4674BE2-4CB9-460F-BD6B-D885A13E03EEQ36543830-77975795-7255-4C76-8D00-B6704EEE4163Q36957941-229E890E-5983-4EEA-AF84-8CBC6A51AFACQ37119226-D10549DF-5C53-42A3-8BA2-B71F2933599FQ37272859-D8A9CE93-C756-4208-ABAA-2531E6F90FADQ37406571-8D84AC08-0BB9-4C27-BC4D-B7B2C65EF717Q37419317-BB7C756A-8EBE-4934-8964-104B8ABB0FA5Q38401928-0B28AE6C-EFC7-43D0-874E-8BA224ED7EA5Q38402291-FC8F3CAC-30C4-4BA4-A317-9974D88625DDQ39621488-81D5912D-6AFA-4222-984E-426EE95472D3Q39983127-41D753BE-09B6-4590-AB8D-888C4EE9CDDAQ40106698-F26E9F1E-AD6B-484F-BE79-287007254E52Q40225076-945E3D69-3A1C-4496-8B11-F7F461898E01Q40785784-5C3A0FF8-A7F6-412B-B1B4-16626CCE102FQ42243024-EDB39132-D2DC-4FE3-BB84-7D46D7E997F0Q43056078-82CB7AFC-780D-48A1-98AD-4C202EB568E0Q50079426-376825EA-83F8-4E5A-9782-0761A4B974EEQ52648768-FE079B0C-C133-430A-AE80-B0A1EA675389Q53791871-8BFC1C5C-BBEF-4957-A224-C04C757CB5AAQ53829397-9EA3E48C-2402-4822-8526-FB5F77CADE4B
P2860
Improvement in the health of HIV-infected persons in care: reducing disparities.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Improvement in the health of HIV-infected persons in care: reducing disparities.
@ast
Improvement in the health of HIV-infected persons in care: reducing disparities.
@en
type
label
Improvement in the health of HIV-infected persons in care: reducing disparities.
@ast
Improvement in the health of HIV-infected persons in care: reducing disparities.
@en
prefLabel
Improvement in the health of HIV-infected persons in care: reducing disparities.
@ast
Improvement in the health of HIV-infected persons in care: reducing disparities.
@en
P2093
P2860
P921
P356
P1476
Improvement in the health of HIV-infected persons in care: reducing disparities.
@en
P2093
Jeanne C Keruly
John G Bartlett
Richard D Moore
P2860
P304
P356
10.1093/CID/CIS654
P407
P577
2012-09-26T00:00:00Z